Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company doctor said.
‘They’re flying blind’: Insurers failing across key customer experience metrics
With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.
Amazon’s ability to attract other employers makes its healthcare coalition very formidable, experts say
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
Five things for pharma marketers to know: Tuesday, January 16, 2018
Merck’s Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark’s Luxturna overpriced, ICER says
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix